Pentobarbital will decrease the level or effect of fentanyl transmucosal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Educador Closely. Coadministration of fentanyl with CYP3A4 inducers could lead to a decrease in fentanyl plasma concentrations, lack of efficacy or, possibly, development of a withdrawal syndrome in a patient who has developed https://qu-es-el-pentobarbital-s65208.blogdomago.com/29469639/es-nembutal-una-pastilla-cosas-que-debe-saber-antes-de-comprar